Unleashing the Power of Genomics to Improve Pet Health
PetDx™ is a team of veterinarians, scientists, and business leaders dedicated to revolutionizing the early detection of cancer in pets. We develop noninvasive cancer testing solutions that incorporate many of the latest advances from the human liquid biopsy space.
PetDx – The Liquid Biopsy Company for Pets™ is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company’s flagship product, OncoK9™, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms empowering veterinarians to provide superior care to canine patients.
Board of Directors
Daniel S. Grosu
Chairman of the Board
Former Chief Medical Officer of Illumina, Former Chief Medical Officer of Sequenom
Jeffrey S. Friedman
Founding Board Member
Managing Partner of Friedman Bioventure Fund, Board Member and Scientific Advisor of DTxPhrama
Want to join the PetDx Pack? We are hiring.
Browse our open positions and submit your application.
Clinical Advisory Board
DVM, MS, DACVIM (Oncology)
Director of The Cancer Institute, Animal Medical Center, NYC
DVM, MS, DACVP
CEO, Clinical Pathology and Quality Assurance Specialist, URIKA LLC
DVM, PhD, DACVS
Associate Professor, Surgery and Bioethics, Oklahoma State University College of Veterinary Medicine
Professor, Surgical Oncology, UC Davis School of Veterinary Medicine
DVM, MS, DACVIM (Oncology)
Assistant Professor, Medical Oncology, University of Missouri College of Veterinary Medicine
DVM, MSEL, DACVIM (SAIM)
Founder of Veterinary Specialty Hospital of San Diego and Co-Founder of Ethos Veterinary Health
DVM, DACVIM (Oncology), DACVR (Radiation Oncology), DECVDI (Radiation Oncology)
Radiation and Medical Oncology; Associate Professor, Radiation Oncology, University of Minnesota College of Veterinary Medicine
Luis A. Diaz
Head, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, & Co-Founder PGDx, Thrive Early Detection
Associate Professor, University of Wisconsin-Madison Center for Human Genomics and Precision Medicine
Associate Director, Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Join the Revolution in Early Cancer Detection for Dogs
If you are eager to incorporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients. Provide your name and email address and we will reach out as we expand our rollout.